Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first
Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first,41398_2023_2379_Fig2_HTML.png,eCase - 2024 EHA Congress MCL Highlights | CCO,Two-year follow-up of KTE-X19 in patients with relapsed or,Age-dependent decline in remyelination capacity is mediated